The best stocks to buy since 1993

Latest issue now available

Volex - Strong Q1 trading

September 2022

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • VLX
  • Price:
  • 262.5p
At the AGM, Volex said Q1 has been strong, and in line with management’s new 5-year growth plan. Sales are ahead by 4.9% (organic) whilst the acquisition pipeline being developed will reinforce growth prospects.  In terms of end market exposures, the EV side has seen strong underlying demand from a growing range of products; Consumer Electrical revenues have continued to grow, as a result of new projects and increased market share; Medical’s demand remains robust and revenues are ahead of Q1 21; and finally, demand in the core business of Complex Industrial Technology is noted as strong with next-generation high speed cable volumes (400Gbs) expected to pick up strongly as replacement programmes accelerate. Singer forecasts ep ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X




To access our archive of articles and to receive current issues you need to subscribe